Ulcerative colitis
Ulcerative colitis is a debilitating and incurable condition. But researchers have found fresh angles of attack, and a host of upcoming treatments raise the prospect of a durable victory against this common form of inflammatory bowel disease.
This Nature Outline is editorially independent. It is produced with third party financial support. About this content.
This Nature Outline is editorially independent, produced with financial support from a third party. About this content.
Nature is pleased to acknowledge the financial support of Translational Research Center for Medical Innovation (TRI) and Himuka AM Pharma Corp. in producing this Outline. The sponsor retains sole responsibility for the following message.
The Translational Research Center for Medical Innovation (TRI), formerly known as Translational Research Informatics Center, was founded in 2002 by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Kobe city to promote academia-originated medical innovation. TRI established the Academic Research Organization (ARO) network in 2013, which is transforming into an Asian ARO network in conjunction with Korea, Taiwan and Singapore. We plan to expand the network globally to Europe and the United States. Our aim is to develop an infrastructure to support the launch of global clinical trials of academia-originated projects and to obtain regulatory approval worldwide.
Himuka AM Pharma Corp. For more information, please visit: https://www.himuka-am.com/
